phasexINTELLIGENCEClient access
METHODOLOGY & TRANSPARENCY

Every conclusion should have a path back to evidence.

PhaseX separates collection, calculation and interpretation. Missing information remains missing; confidence and comparability are displayed rather than hidden.

01

Collect

Public SEC filings, CompanyFacts/XBRL facts and stored market snapshots are collected with identifiers, dates and accession numbers.

02

Normalize

Financial periods, units and company types are aligned. Banks, insurers, REITs and operating companies are not treated as identical businesses.

03

Calculate

Deterministic formulas produce health, intelligence and valuation layers. No missing financial value is invented to complete a score.

04

Explain

Client-facing research uses bands, direction and plain-language context. Every material insight retains its source and formula version.

What PhaseX does not claim

A strong health band does not mean that a security is attractively priced. A weak valuation band does not mean the business is weak. Neither is a prediction of stock performance.

Data coverage and confidence

Company histories vary from two to eighteen years. Some valuation records are unavailable, and comparability can be limited. When evidence is insufficient, the correct output is "limited data" — not a fabricated estimate.